Top Markets
Coin of the day
Eiger BioPharmaceuticals, Inc. Eiger BioPharmaceuticals, Inc.

Eiger BioPharmaceuticals, Inc.

EIGR
Classificação em ações #36561
Eiger BioPharmaceuticals, Inc. is a commercial-stage biopharmaceutical company... Eiger BioPharmaceuticals, Inc. is a commercial-stage biopharmaceutical company dedicated to developing and bringing to market targeted therapies for rare and ultra-rare diseases across the United States and internationally. Its primary investigational drug, Lonafarnib, an orally administered small molecule, is currently undergoing Phase III clinical trials for the treatment of hepatitis delta virus (HDV) infection. Other promising candidates in its portfolio include Lambda, which has completed Phase II clinical trials and is designed to target type III interferon receptors; Lonafarnib, also being evaluated for progeria and progeroid laminopathies; and Avexitide, an agent for congenital hyperinsulinism that has also successfully concluded Phase II studies for post-bariatric hypoglycemia. Established in 2008, Eiger BioPharmaceuticals, Inc. maintains its headquarters in Palo Alto, California.
Preço da ação
$1.73
Última sincronização: 2025-06-17
Valor de mercado
$2.55M
Variação (1 dia)
-0.29%
Variação (1 ano)
0.00%
País
US
Negociar Eiger BioPharmaceuticals, Inc. (EIGR)

Categoria

Preço EIGR com a capitalização de mercado de B
Eiger BioPharmaceuticals, Inc. Eiger BioPharmaceuticals, Inc.
EIGR
$1.73
Capitalização de mercado de Eiger BioPharmaceuticals, Inc.(EIGR)
Valor de mercado: $2.55M
Em August 2026, Eiger BioPharmaceuticals, Inc. tem uma capitalização de mercado de $2.55M. Isso faz com que Eiger BioPharmaceuticals, Inc. seja a 36561st empresa mais valiosa do mundo em termos de capitalização de mercado, de acordo com os nossos dados. A capitalização de mercado, também chamada de market cap, é o valor total de mercado das ações em circulação de uma empresa de capital aberto e é amplamente utilizada para medir o valor de uma empresa.
Histórico de capitalização de mercado de Eiger BioPharmaceuticals, Inc. de 2014 a 2026
EIGR comparado com o topo de 5 mais populares stocks
Preço para EIGR Ativo B Capitalização de mercado de B Resultados
Eiger BioPharmaceuticals, Inc. Eiger BioPharmaceuticals, Inc.
$3,684,828 $2.55M
$5.452T +213,613,124.72%
Eiger BioPharmaceuticals, Inc. Eiger BioPharmaceuticals, Inc.
$3,034,731 $2.55M
$4.490T +175,926,341.05%
Eiger BioPharmaceuticals, Inc. Eiger BioPharmaceuticals, Inc.
$2,813,303 $2.55M
$4.162T +163,089,914.17%
Eiger BioPharmaceuticals, Inc. Eiger BioPharmaceuticals, Inc.
$2,484,780 $2.55M
$3.676T +144,045,097.36%
Eiger BioPharmaceuticals, Inc. Eiger BioPharmaceuticals, Inc.
$1,914,807 $2.55M
$2.833T +111,003,211.28%